# Intensity Therapeutics, Inc.: Form 8-K, filed Mar 14, 2024

- Company: [Intensity Therapeutics, Inc.](/companies/ints.md) (CIK 1567264)
- Form: 8-K
- Filed: 2024-03-14
- Accepted by EDGAR: Mar 14, 2024, 16:12 ET
- Period: 2024-03-14
- Accession: 0001628280-24-011219
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1567264/000162828024011219/intensity-20240314.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1567264/000162828024011219/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1567264/000162828024011219/intensity-20240314.htm

Filed Mar 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-011219. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.